Related Experiment Video
Updated: Aug 22, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal and postnatal steroid therapy and child neurodevelopment
Smadar Friedman1, Eric S Shinwell
1Department of Neonatology, Kaplan Medical Center, PO Box 1, Rehovot 76100, Israel. smadar_e@clalit.org.il
Insights
Perinatal steroid therapy may harm developing brains in preterm infants. Guidelines recommend limited steroid use to balance lung disease reduction with neurodevelopmental safety.
Area of Science:
- Neonatal care
- Neurodevelopmental research
- Pharmacology
Background:
- Accumulating evidence suggests potential neurotoxic effects of perinatal steroid therapy on immature brains.
- The developing fetal and preterm infant brain is particularly vulnerable to exogenous substances.
Purpose of the Study:
- To review current recommendations and evidence regarding the optimal use of steroids in preterm infants.
- To minimize lung disease while preventing adverse neurodevelopmental outcomes.
Main Methods:
- Review of current clinical guidelines and scientific literature.
- Analysis of the risks and benefits of prenatal and postnatal steroid administration.
Main Results:
- National Institutes of Health (NIH) guidelines recommend a single course of prenatal steroids for imminent preterm delivery.
- American Association of Pediatrics (AAP) guidelines advocate limiting postnatal steroid therapy to specific cases after the first week of life.
Conclusions:
- Careful consideration and limitation of steroid therapy are crucial in high-risk neonates.
- Balancing the benefits for lung disease with potential neurodevelopmental risks is paramount.
Abstract:
In recent years, scientific evidence has accumulated on the potential neuro-toxic effects of perinatal steroid therapy on the incompletely developed brain; therefore, much effort has been directed toward finding the optimal regimen that may reduce lung disease without incurring significant brain injury in fetuses and preterm infants. Current recommendations of the NIH endorse a single course of prenatal steroids in cases of imminent preterm delivery. Postnatal steroid therapy should be limited, according to the American Association of Pediatrics Guide-lines, to selected clinical cases after the first week of life. These cautions aim to decrease possible harmful effects that could affect short- and long-term neuro-developmental outcome in this high-risk population.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Related Concept Videos
Teratogenicity
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.